ES2042153T3 - Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion. - Google Patents

Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion.

Info

Publication number
ES2042153T3
ES2042153T3 ES199090114108T ES90114108T ES2042153T3 ES 2042153 T3 ES2042153 T3 ES 2042153T3 ES 199090114108 T ES199090114108 T ES 199090114108T ES 90114108 T ES90114108 T ES 90114108T ES 2042153 T3 ES2042153 T3 ES 2042153T3
Authority
ES
Spain
Prior art keywords
parts
weight
treatment
pain states
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199090114108T
Other languages
English (en)
Inventor
Manfred Lohner
Klaus Dr. Posselt
Ute Dr. Med. Vogtle-Junkert
Hans H. Prof. Dr. Med. Wagener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dolorgiet GmbH and Co KG
Original Assignee
Dolorgiet GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolorgiet GmbH and Co KG filed Critical Dolorgiet GmbH and Co KG
Application granted granted Critical
Publication of ES2042153T3 publication Critical patent/ES2042153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Instructional Devices (AREA)
  • Endoscopes (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

EL INVENTO SE REFIERE A UN MEDIO QUE SE UTILIZA PARA EL TRATAMIENTO DE ESTADOS DE DOLOR AGUDO COMO DOLORES POSOPERATIVOS Y DOLORES TUMULARES Y CONSISTE EN CAPSULAS DE GELATINA BLANDAS QUE CONTIENEN DE 30 A 50 PARTES EN PESO DE IBUPROFEN Y DE 1,5 A 4 PARTES EN PESO DE CODEINA Y SUS SALES TOLERABLES FISIOLOGICAMENTE QUE PARCIALMENTE SE DILUYEN Y SE SUSPENDEN EN 68,5 A 48 PARTES EN PESO DE POLIOXIETILENO UNA MEZCLA DE 30 A 76 PARTES EN PESO DE POLIOXIETILENO XIPROPILENO A 40 PARTES EN PESO DE UNOS TENSIOACTIVOS TOLERABLES FISIOLOGICAMENTE.
ES199090114108T 1989-08-17 1990-07-24 Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion. Expired - Lifetime ES2042153T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927113A DE3927113C2 (de) 1989-08-17 1989-08-17 Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2042153T3 true ES2042153T3 (es) 1993-12-01

Family

ID=6387265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199090114108T Expired - Lifetime ES2042153T3 (es) 1989-08-17 1990-07-24 Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion.

Country Status (12)

Country Link
US (1) US5173304A (es)
EP (1) EP0413171B1 (es)
JP (1) JPH03169809A (es)
AT (1) ATE89730T1 (es)
CA (1) CA2023349A1 (es)
DE (2) DE3927113C2 (es)
DK (1) DK0413171T3 (es)
ES (1) ES2042153T3 (es)
FI (1) FI904092A7 (es)
NO (1) NO903608L (es)
YU (1) YU149290A (es)
ZA (1) ZA906486B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
GB2260081B (en) * 1991-10-04 1995-11-29 Euro Celtique Sa Use of ibuprofen/codeine mixtures in treatment of chronic pain
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5468502A (en) * 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
WO1999017744A1 (en) * 1997-10-07 1999-04-15 Fuisz Technologies Ltd. Immediate release drug delivery forms
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US20040097472A1 (en) * 2000-11-14 2004-05-20 West Simon Michael Complexes of phosphate derivatives
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
MXPA04000654A (es) * 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
WO2003049774A1 (en) * 2001-12-13 2003-06-19 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
JP4690305B2 (ja) * 2003-01-17 2011-06-01 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗増殖性質を有する化合物
TWI367113B (en) * 2003-02-12 2012-07-01 Syncera Inc Random and non-random alkylene oxide polymer alloy compositions
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
RU2477136C2 (ru) * 2004-03-03 2013-03-10 Вайтал Хэлф Сайнсис Пти Лтд Алкалоидные составы
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
US9168216B2 (en) * 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US20090005348A1 (en) * 2005-12-23 2009-01-01 Vital Health Sciences Pty Ltd Compounds Having Cytokine Modulating Properties
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
US20100030576A1 (en) * 2008-07-30 2010-02-04 Mclane Advanced Technologies, Llc System and Method for Pain Management
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4894234A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for antiarrhythmics
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4923898A (en) * 1984-12-26 1990-05-08 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
JPH03169809A (ja) 1991-07-23
DE3927113A1 (de) 1991-02-21
DK0413171T3 (da) 1993-10-04
DE3927113C2 (de) 1993-11-25
FI904092A7 (fi) 1991-02-18
NO903608D0 (no) 1990-08-16
FI904092A0 (fi) 1990-08-17
NO903608L (no) 1991-02-18
ZA906486B (en) 1991-06-26
EP0413171A1 (de) 1991-02-20
DE59001544D1 (de) 1993-07-01
US5173304A (en) 1992-12-22
EP0413171B1 (de) 1993-05-26
YU149290A (sh) 1992-12-21
CA2023349A1 (en) 1991-02-18
ATE89730T1 (de) 1993-06-15

Similar Documents

Publication Publication Date Title
ES2052914T3 (es) Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2169105T3 (es) Agentes antitromboticos tripeptidicos.
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
ES2140847T3 (es) Procedimientos y formulaciones para modular la respuesta sexual humana.
ES2084944T3 (es) Amidas terapeuticas.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
ES2061452T3 (es) Nuevas hetrazepinas y procedimiento para su preparacion.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
FR2620941B1 (fr) Vaccin contenant des adjuvants et des antigenes tumoraux
ES2048557T3 (es) Composiciones para el cuidado de la piel.
PE30891A1 (es) Composiciones y metodos terapeuticos sinergicos
ES2073574T3 (es) Introduccion de liposomas en el tejido isquemico.
DK0413171T3 (da) Middel til behandling af svære smertetilstande og fremgangsmåde til fremstilling heraf
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2066062T3 (es) Preparacion de liberacion sostenida para administracion al cerebro.
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
ES2105285T3 (es) Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413171

Country of ref document: ES